BioNTech

Leadership Transition and Financial Headwinds Weigh on BioNTech Shares

angelina - March 11, 2026

百欧恩泰转型之路：千亿现金储备押注肿瘤治疗新纪元

Brett Shapiro - March 9, 2026

BioNTech Shares Face Critical Test Amid Strategic Pivot

angelina - March 8, 2026

BioNTech Shares Face Technical Test Ahead of Earnings

Brett Shapiro - March 7, 2026

BioNTech财报前瞻：关键动向与市场博弈

kashif hafeez - March 7, 2026

BioNTech面临巨额法律风险，投资者聚焦财报日

Brett Shapiro - March 5, 2026

BioNTech三月展望：战略转型与专利博弈并行

March 1, 2026

BioNTech’s Financial Milestone Approaches as Strategic Pivot Continues

February 27, 2026

BioNTech财报前夜：专利战火重燃，转型之路迎关键考验

February 26, 2026

专利战火再起：BioNTech在美国法院起诉Moderna新疫苗侵权

kashif hafeez - February 25, 2026

BioNTech再掀专利诉讼战，肿瘤管线转型同步推进

kashif hafeez - February 22, 2026

BioNTech股价再获强心剂：真实世界研究证实加强针效力

kashif hafeez - February 20, 2026

BioNTech股价：关键数据发布前的蓄势期

angelina - February 10, 2026

BioNTech转型攻坚：后疫情时代的生死时速

angelina - February 6, 2026

分析师为BioNTech股价降温：抗癌管线加速推进，但短期估值已高？

kashif hafeez - February 5, 2026

1...456...9 Page 5 of 9